Citation Tools
PDFLate-breaking abstracts
Clinical trials completed
793 TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) human papilloma virus (HPV)-16+ cancers: clinical efficacy and immunogenicity
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 793 TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) human papilloma virus (HPV)-16+ cancers: clinical efficacy and immunogenicity